Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cone Rod Dystrophy Market Intelligence Report, 2026 Edition - Asia-Pacific Set to Become Fastest Growing Region Driven by Supportive Government Policies and Significant Investments in Biotechnology

globenewswire.com
MGTX MeiraGTx Limited is identified as a company in the cone rod dystrophy market, but the article does not offer specific sentiment or performance details.

Cone Rod Dystrophy Market Intelligence Report, 2026 Edition - Asia-Pacific Set to Become Fastest Growing Region Driven by Supportive Government Policies and Significant Investments in Biotechnology Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Cone Rod Dystrophy Market: 2026 Edition" has been added to ResearchAndMarkets.com's offering.

The global cone rod dystrophy market is witnessing substantial growth, with its value projected to reach US$177.59 million by 2030, expanding at a CAGR of 5.33% from 2025 to 2030. This growth is primarily driven by heightened awareness of genetic disorders and the increasing demand for effective treatments. In the US, cone rod dystrophy affects about 1 in 40,000 individuals, underscoring the need for innovative therapies.

Historically, treatment options are geared towards slowing disease progression and enhancing quality of life. The introduction of potential therapies such as gene therapy, stem cell therapy, and retinal implants marks a new era of hope for patients. The market segmentation encompasses various approaches:

Market Segmentation:

Market Dynamics:

Impact of COVID-19 and Future Outlook

While the pandemic initially disrupted the market, it also reignited interest in gene and stem cell therapies as legitimate treatment pathways, setting the stage for future growth bolstered by accelerated regulatory approvals.

Competitive Landscape

The market features key players like SparingVision, Beacon Therapeutics, and Nanoscope Therapeutics. Mergers and acquisitions are prevalent as companies strive for competitive advantage. Recent innovations, such as SparingVision's SPVN06, demonstrate promising potential in treating a broad spectrum of genetic mutations.

Key Topics Covered

1. Executive Summary

2. Introduction

2.1 Cone Rod Dystrophy: An Overview

2.1.1 Introduction to Cone Rod Dystrophy

2.2 Cone Rod Dystrophy Segmentation: An Overview

2.2.1 Cone Rod Dystrophy Segmentation

3. Global Market Analysis

3.1 Global Cone Rod Dystrophy Market: An Analysis

3.1.1 Global Cone Rod Dystrophy Market: An Overview

3.1.2 Global Cone Rod Dystrophy Market by Value

3.1.3 Global Cone Rod Dystrophy Market by Type (X-Linked Cone Rod Dystrophy, Autosomal Dominant Cone Rod Dystrophy, and Autosomal Recessive Cone Rod Dystrophy)

3.1.4 Global Cone Rod Dystrophy Market by Treatment Type (Gene Therapy, Stem Cell Therapy, Retinal Implant Surgery, and Others)

3.1.4 Global Cone Rod Dystrophy Market by End User (Hospitals, Specialty Clinics, and Others)

3.1.5 Global Cone Rod Dystrophy Market by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America)

3.2 Global Cone Rod Dystrophy Market: Type Analysis

3.2.1 Global Cone Rod Dystrophy Market by Type: An Overview

3.2.2 Global X-Linked Cone Rod Dystrophy Market by Value

3.2.3 Global Autosomal Dominant Cone Rod Dystrophy Market by Value

3.2.4 Global Autosomal Recessive Cone Rod Dystrophy Market by Value

3.3 Global Cone Rod Dystrophy Market: Power Source Analysis

3.3.1 Global Cone Rod Dystrophy Market by Treatment Type: An Overview

3.3.2 Global Gene Therapy Cone Rod Dystrophy Market by Value

3.3.3 Global Stem Cell Therapy Cone Rod Dystrophy Market by Value

3.3.4 Global Retinal Implant Surgery Cone Rod Dystrophy Market by Value

3.3.5 Global Others Cone Rod Dystrophy Market by Value

3.4 Global Cone Rod Dystrophy Market: End User Analysis

3.4.1 Global Cone Rod Dystrophy Market by End User: An Overview

3.4.2 Global Hospitals Cone Rod Dystrophy Market by Value

3.4.3 Global Specialty Clinics Cone Rod Dystrophy Market by Value

3.4.4 Global Others Cone Rod Dystrophy Market by Value

4. Regional Market Analysis

4.1 North America Cone Rod Dystrophy Market: An Analysis

4.1.1 North America Cone Rod Dystrophy Market: An Overview

4.1.2 North America Cone Rod Dystrophy Market by Value

4.1.3 North America Cone Rod Dystrophy Market by Region (The US, Canada and Mexico)

4.1.4 The US Cone Rod Dystrophy Market by Value

4.1.5 Canada Cone Rod Dystrophy Market by Value

4.1.6 Mexico Cone Rod Dystrophy Market by Value

4.2 Europe Cone Rod Dystrophy Market: An Analysis

4.2.1 Europe Cone Rod Dystrophy Market: An Overview

4.2.2 Europe Cone Rod Dystrophy Market by Value

4.2.3 Europe Cone Rod Dystrophy Market by Region (Germany, UK, France, Italy, and Rest of Europe)

4.2.4 Germany Cone Rod Dystrophy Market by Value

4.2.5 UK Cone Rod Dystrophy Market by Value

4.2.6 France Cone Rod Dystrophy Market by Value

4.2.7 Italy Cone Rod Dystrophy Market by Value

4.2.8 Rest of Europe Cone Rod Dystrophy Market by Value

4.3 Asia-Pacific Cone Rod Dystrophy Market: An Analysis

4.3.1 Asia-Pacific Cone Rod Dystrophy Market: An Overview

4.3.2 Asia-Pacific Cone Rod Dystrophy Market by Value

4.3.3 Asia-Pacific Cone Rod Dystrophy Market by Region (China, India, Japan, South Korea, and Rest of Asia-Pacific)

4.3.4 China Cone Rod Dystrophy Market by Value

4.3.5 Japan Cone Rod Dystrophy Market by Value

4.3.6 India Cone Rod Dystrophy Market by Value

4.3.7 South Korea Cone Rod Dystrophy Market by Value

4.3.8 Rest of Asia-Pacific Cone Rod Dystrophy Market by Value

4.4 Middle East & Africa Cone Rod Dystrophy Market: An Analysis

4.4.1 Middle East & Africa Cone Rod Dystrophy Market: An Overview

4.4.2 Middle East & Africa Cone Rod Dystrophy Market by Value

4.5 Latin America Cone Rod Dystrophy Market: An Analysis

4.5.1 Latin America Cone Rod Dystrophy Market: An Overview

4.5.2 Latin America Cone Rod Dystrophy Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19 on Global Cone Rod Dystrophy Market

5.2 Post COVID-19 Impact on Global Cone Rod Dystrophy Market

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Increasing Prevalence of Cone Rod Dystrophy

6.1.2 Rise in Research and Development Activities

6.1.3 Growing Incidence of Rare Genetic Disorders

6.1.4 Rising Awareness about Cone Rod Dystrophy

6.1.5 Rising Healthcare Expenditure

6.1.6 Gene Therapy for Cone Rod Dystrophy

6.2 Challenges

6.2.1 Limited Patient Pool

6.2.2 Regulatory and Safety Considerations

6.3 Market Trends

6.3.1 Surge in Clinical Trials

6.3.2 Development of Novel Therapies

6.3.3 Newer Techniques Help in Early Detection

7. Competitive Landscape

7.1 Global Cone Rod Dystrophy Market: Recent Developments

7.2 Global Cone Rod Dystrophy Market Players: Current Landscape

8. Company Profiles

8.1 SparingVision

8.1.1 Business Overview

8.1.2 Business Strategies

8.2 Beacon Therapeutics

8.2.1 Business Overview

8.2.2 Business Strategies

8.3 Nanoscope Therapeutics, Inc.

8.3.1 Business Overview

8.3.2 Business Strategies

8.4 MeiraGTx Limited

8.4.1 Business Overview

8.4.2 Business Strategies

8.5 Ascidian Therapeutics, Inc.

8.5.1 Business Overview

8.5.2 Business Strategies

8.6 jCyte, Inc.

8.6.1 Business Overview

8.6.2 Business Strategies

8.7 BlueRock Therapeutics L.P.

8.7.1 Business Overview

8.7.2 Business Strategies

8.8 Zhongmou Therapeutics

8.8.1 Business Overview

8.8.2 Business Strategy

For more information about this report visit https://www.researchandmarkets.com/r/vft3l0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.